<DOC>
	<DOCNO>NCT02989740</DOCNO>
	<brief_summary>Title : Combined Optical Coherence Tomography Morphologic Fractional Flow Reserve Hemodynamic Assessment Non-Culprit Lesions Better Predict Adverse Event Outcomes Diabetes Mellitus Patients COMBINE ( OCT-FFR ) Prospective Register To study natural evolution patient least one intermediate angiographic non-hemodynamic significant stenotic lesion , two subgroup patient , TCFA vs. TCFA detect OCT image compare two group patient well subset patient FFR-positive PCI-treated intermediate lesion future MACE .</brief_summary>
	<brief_title>Optical Coherence Tomography Morphologic Fractional Flow Reserve Assessment Diabetes Mellitus Patients</brief_title>
	<detailed_description>Hypothesis Diabetes Mellitus ( DM ) patient angiographically intermediate coronary lesion remain risk future MACE event , include patient fractional flow reserve ( FFR ) negative lesion . Use FFR measurement combine Optimal Coherence Tomography ( OCT ) detection thin-cap fibroatheroma ( TCFA ) help predict future MACE rate . Objective To study natural evolution patient least one intermediate angiographic non-hemodynamic significant stenotic lesion , two subgroup patient , TCFA vs. TCFA detect OCT image compare two group patient well subset patient FFR-positive PCI-treated intermediate lesion future MACE . Design Prospective , open label natural history registry . DM patient bear target lesion { Any de novo lesion angiographic visual estimation ≥ 40 % - ≤ 80 % Diameter Stenosis ( DS ) locate non-grafted coronary segment . In patient MI presentation target lesion different culprit lesion } undergone FFR OCT image clinical routine prospectively enrol follow . Patients negative FFR ( &gt; 0.80 ) divide two category depend corelab OCT image finding : No-TCFA ( cap thickness &gt; 65µ ) ( Group A ) TCFA ( cap thickness ≤ 65µ ) ( group B ) . All patient positive FFR therefore treat PCI per standard care target lesion also follow ( group C ) , however PCI least one remain target lesion FFR negative patient follow group A B depend OCT finding . Clinical endpoint 1.5 year record . The investigator strongly recommend major epicardial coronary vessel stentable size show form atherosclerosis interrogate FFR OCT . The investigator strongly recommend perform cap thickness measurement cathlab . The plaque cap thickness measure corelab disclose operator patient . Population Patients age ≥18 year Diabetes mellitus ( DM ) patient presentation . Coronary angiography , FFR OCT image least one coronary de novo stenosis native vessel visually estimate diameter stenosis ( DS ) ≥ 40 % -≤ 80 % ( target lesion ) . Angiographic criterion target lesion : ( ) ≥ 40 % -≤ 80 % diameter stenosis ( DS ) ( ii ) de novo lesion locate native non-grafted vessel ( iii ) target lesion reference diameter ≥ 2.0 mm ( iv ) TIMI 3 flow Primary Endpoint The per patient incidence target lesion ( ) relate composite MACE define Cardiac Death , MI , clinically-driven target lesion revascularisation hospitalization due unstable progressive angina 18 month FFR-negative No-TCFA ( Group A ) FFR-negative TCFA ( Group B ) . Statistics This observational study ( prospective natural history register ) randomization take place , therefore power calculation strictly necessary . However , order observe meaningful difference group ( described design ) deduct found conclusion , minimal number patient require calculated follow . The target lesion related primary endpoint 18 month A B group respectively assume 5 % 20 % respectively . Taking account expect loss FU 7 % , total 500 patient enrol study provide 80 % power reject null hypothesis 5 % type I error ( alpha ) . The enrolment group C stop first 166 patient enrol group . The rest rest 334 patient distribute group A B depend OCT corelab finding . Nul hypothesis : MACE rate group B different group A .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>1 . Age ≥ 18 year 2 . History DM indication angiography ( Stable Angina ( SA ) type Acute Coronary Syndrome ( ACS ) include STElevation MI ) . 3 . Coronary angiography , include FFR OCT image least one coronary de novo stenosis native notgrafted vessel visually estimate diameter stenosis ( DS ) ≥ 40 ≤ 80 % ( target lesion ) . Target lesion culprit lesion ( ) patient present MI ( STEMI nonSTEMI ) . 1 . TIMI flow &lt; 3 target lesion ( ) 2 . Target lesion reference diameter ( visual estimation ) &lt; 2.0 mm 3 . Known leave ventricular ejection fraction &lt; 30 % 4 . Known malignancy 5 . Life expectancy &lt; 2 year 6 . Unwilling unable provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Thincap fibroatheroma</keyword>
	<keyword>Optical Coherence Tomography</keyword>
	<keyword>Fractional Flow Reserve</keyword>
</DOC>